Second line therapy for nsclc
Nuovi inibitori irreversibili di EGFR Cesare Gridelli Division of Medical Oncology “S.G. Moscati” Hospital – Avellino (Italy) [email protected] [email protected].
Jordi Bruix Head, BCLC Group, Liver Unit Hospital Clínic, University of Barcelona New drugs for Hepatocellular Carcinoma.
